Literature DB >> 2721266

Hemodynamic and gas exchange alterations during Intralipid infusion in patients with adult respiratory distress syndrome.

B Venus1, R A Smith, C Patel, E Sandoval.   

Abstract

Hemodynamic and pulmonary gas exchange consequences of 20 percent intravenous fat emulsion infusion (3.0 +/- .3 mg/kg/min) were evaluated in 19 patients who demonstrated ARDS. Lipid infusion precipitated a significant reduction in PaO2/FIO2 from 241 +/- 50 to 184 +/- 41 (mean +/- SD) and increased MPAP from 26.0 +/- 5.1 to 31.8 +/- 4.8 mm Hg, pulmonary vascular resistance from 149 +/- 78 to 179 +/- 61 dyne.s/cm5 and pulmonary venous admixture (Qva/Qt) from 20.7 +/- 15.2 to 30.6 +/- 8.6 percent. Further analysis revealed that the magnitude of increased Qva/Qt was greater in patients who manifested septicemia (N = 10) compared to those who did not (N = 9): 12.3 vs 7.3 percent, respectively. We conclude that intravenous lipid administration was associated with increased MPAP and Qva/Qt in patients with ARDS, particularly when accompanied by septicemia. Although these alterations resolved after the lipid infusion was terminated, we suggest that prudent measures should be taken to guarantee adequate oxygenation during intravenous fat emulsion therapy in patients suffering from ARDS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2721266     DOI: 10.1378/chest.95.6.1278

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study.

Authors:  Omar Wever-Pinzon; Valentin Suma; Ameeta Ahuja; Jorge Romero; Nishtha Sareen; Sonia A Henry; Maria De Benedetti Zunino; Farhan F Chaudhry; Ramya S Suryadevara; Mark V Sherrid; Farooq A Chaudhry
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-03-16       Impact factor: 6.875

Review 2.  Intravenous fat emulsion: a potential novel antidote.

Authors:  Danielle E Turner-Lawrence; William Kerns Ii
Journal:  J Med Toxicol       Date:  2008-06

Review 3.  [Calories, proteins - what does the intensive care patient need?].

Authors:  A Schäfer
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-01-12       Impact factor: 0.840

4.  Obesity-Induced Endoplasmic Reticulum Stress Causes Lung Endothelial Dysfunction and Promotes Acute Lung Injury.

Authors:  Dilip Shah; Freddy Romero; Zhi Guo; Jianxin Sun; Jonathan Li; Caleb B Kallen; Ulhas P Naik; Ross Summer
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

5.  Survival following massive amitriptyline overdose: The use of intravenous lipid emulsion therapy and the occurrence of acute respiratory distress.

Authors:  David Radley; Sarah Droog; John Barragry; Colin Bigham
Journal:  J Intensive Care Soc       Date:  2015-04-14

6.  Effect of arachidonic and eicosapentaenoic acids on acute lung injury induced by hypochlorous acid.

Authors:  H Wahn; N Rüenauver; S Hammerschmidt
Journal:  Thorax       Date:  2002-12       Impact factor: 9.139

7.  Gas exchange and pulmonary haemodynamic responses to fat emulsions in acute respiratory distress syndrome.

Authors:  J R Masclans; R Iglesia; B Bermejo; M Picó; R Rodriguez-Roisin; M Planas
Journal:  Intensive Care Med       Date:  1998-09       Impact factor: 17.440

8.  Fat emulsions containing medium chain triglycerides in patients with sepsis syndrome: effects on pulmonary hemodynamics and gas exchange.

Authors:  P Radermacher; B Santak; H Strobach; K Schrör; J Tarnow
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 9.  Intravenous nutritional support and the surgeon: where next?

Authors:  D J Hehir; T F Gorey
Journal:  Ir J Med Sci       Date:  1992-06       Impact factor: 1.568

10.  Effects of an omega-3 fatty acid-enriched lipid emulsion on eicosanoid synthesis in acute respiratory distress syndrome (ARDS): A prospective, randomized, double-blind, parallel group study.

Authors:  Joan Sabater; Joan Ramon Masclans; Judit Sacanell; Pilar Chacon; Pilar Sabin; Mercè Planas
Journal:  Nutr Metab (Lond)       Date:  2011-04-08       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.